Want to see IN:BOROSCI full AI Analyst Report?
BOROSCI Stock Chart & Stats
₹135.15
₹0.10(0.06%)
At close: 4:00 PM EST
₹135.15
₹0.10(0.06%)
Day’s Range― - ―
52-Week Range₹96.65 - ₹181.25
Previous CloseN/A
Volume4.27K
Average Volume (3M)6.01K
Market Cap
₹12.24B
Enterprise Value₹10.28K
Total Cash (Recent Filing)₹1.20B
Total Debt (Recent Filing)₹88.69M
Price to Earnings (P/E)28.0
Beta1.14
Next Earnings
Nov 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.29
Shares Outstanding88,947,050
10 Day Avg. Volume4,034
30 Day Avg. Volume6,014
Financial Highlights & Ratios
PEG Ratio0.92
Price to Book (P/B)2.08
Price to Sales (P/S)1.96
P/FCF Ratio65.46
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low leverage and an improving equity base provide durable financial flexibility. This reduces refinancing risk, lowers interest burden and enables the firm to support working capital, selective capex or acquisitions, preserving operational continuity and optionality over months.
Sustained Revenue And Profit GrowthConsistent top-line expansion with higher operating profit and net income reflects growing market penetration and demand for lab products. Durable revenue growth supports reinvestment in products and distribution, underpinning medium-term earnings power despite margin variability.
Repeatable Consumables Revenue StreamsA significant portion of sales comes from consumables and repeat purchases to institutions and labs. This creates predictable, recurring demand and stable order cadence, reducing revenue volatility and supporting steady cash inflows across 2-6 month horizons.
Bears Say
Weakened Cash GenerationMaterial deterioration in operating and free cash flow reduces earnings quality and limits internal funding for capex, inventory and growth initiatives. Sustained weak cash conversion can force external financing or constrain expansion plans over the medium term.
Margin PressureDeclining gross and EBITDA margins indicate cost or pricing headwinds that erode per-unit profitability. If persistent, this reduces free cash generation and the ability to fund R&D or sales expansion, limiting sustainable earnings growth over coming quarters.
Moderate Returns On EquityROE that is only moderate implies the company is not yet converting equity growth into high incremental profit. Continued moderate capital efficiency could weigh on long-term shareholder value unless operational margins or asset turnover improve in the medium term.
Borosil Scientific Limited News
BOROSCI FAQ
What was Borosil Scientific Limited’s price range in the past 12 months?
Borosil Scientific Limited lowest stock price was ₹96.65 and its highest was ₹181.25 in the past 12 months.
What is Borosil Scientific Limited’s market cap?
Borosil Scientific Limited’s market cap is ₹12.24B.
When is Borosil Scientific Limited’s upcoming earnings report date?
Borosil Scientific Limited’s upcoming earnings report date is Nov 17, 2026 which is in 97 days.
How were Borosil Scientific Limited’s earnings last quarter?
Borosil Scientific Limited released its earnings results on Aug 03, 2026. The company reported ₹0.491 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Borosil Scientific Limited overvalued?
According to Wall Street analysts Borosil Scientific Limited’s price is currently Overvalued.
Does Borosil Scientific Limited pay dividends?
Borosil Scientific Limited does not currently pay dividends.
What is Borosil Scientific Limited’s EPS estimate?
Borosil Scientific Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Borosil Scientific Limited have?
Borosil Scientific Limited has 88,947,050 shares outstanding.
What happened to Borosil Scientific Limited’s price movement after its last earnings report?
Borosil Scientific Limited reported an EPS of ₹0.491 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.61%.
Which hedge fund is a major shareholder of Borosil Scientific Limited?
Currently, no hedge funds are holding shares in IN:BOROSCI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Borosil Scientific Limited
Established in 1962 and headquartered in Mumbai, India, Borosil Scientific Limited is a specialist in the manufacturing and distribution of a wide array of laboratory products. Its comprehensive portfolio includes essential lab glassware and consumables like filtration items and analytical vials. The company also supplies advanced laboratory instrumentation designed for applications in nutrition, environmental studies, life essentials, life sciences, and liquid handling. Furthermore, Borosil Scientific produces primary packaging materials for pharmaceuticals, such as glass ampoules and tubular glass vials. Their offerings extend to sophisticated laboratory process systems, which feature various reactor types (mini, jacketed, parallel, automated, photo/specialty) and utility components, alongside Industrial Process Equipment and Original Equipment Manufacturing (OEM) solutions. The company caters to diverse sectors, including pharmaceutical, chemical, research, agricultural, food and beverage, and environmental industries. Formerly known as Klass Pack Limited, the company officially adopted the Borosil Scientific Limited name in December 2023.
Technical Analysis
Jindal Poly Films Limited
―
Mold Tek Packaging Ltd
―
TCPL Packaging Limited
―
Time Technoplast Limited
―
UFlex Limited
―